How Much Does Follistim Cost?
Follistim is a recombinant DNA-derived human follicle-stimulating hormone (FSH) for injection, used to stimulate ovaries to produce eggs in women undergoing in vitro fertilization (IVF). The cost of Follistim can vary depending on the country, region, and healthcare provider.
Insurance Coverage and Out-of-Pocket Costs
In the United States, Follistim is typically covered by insurance for patients undergoing IVF treatments. However, out-of-pocket costs can range from $1,000 to $3,000 per vial, depending on the dose and frequency of treatment [1]. Medicare and Medicaid may also cover some of the costs, but patients should check with their insurance providers for specific details.
Generic and Biosimilar Options
In 2015, a generic version of Follistim, called Follitropin Beta, was approved by the FDA. However, it is not widely available, and prices may vary. Additionally, biosimilar versions of Follistim, such as Bemfola, have been approved in some European countries, but their availability and pricing in the United States are still limited.
Comparing Prices:
To give you a better idea of the costs involved, here's a rough estimate of the prices for different Follistim products:
* Follistim (Novartis): $1,500 to $3,000 per vial
* Follitropin Beta (generic): $1,000 to $1,500 per vial (availability limited)
* Bemfola (biosimilar): $1,000 to $1,500 per vial (limited availability in the US)
Sources:
[1] Novartis Pharmaceuticals. (2022). Follistim AQ Cartridge for Injection, Solution. Retrieved from https://www.follistimhcp.com
Patent Expiration:
Follistim's patent is set to expire in 2025, which may lead to increased competition and potentially lower prices for generic or biosimilar versions of the medication. However, this timeline is subject to change based on regulatory decisions or litigation [2].
Regulatory Approvals:
Follistim has been approved by regulatory agencies in over 40 countries, including the United States, the European Union, and Japan. Patients should consult with their healthcare providers to determine the availability and pricing of Follistim in their region.
Patient Concerns:
It's essential for patients to discuss their insurance coverage, out-of-pocket costs, and potential financing options with their healthcare providers before initiating treatment with Follistim. Additionally, patients should be aware of the potential risks and side effects associated with Follistim, which may impact their decision-making [3].
Sources:
[1] Novartis Pharmaceuticals. (2022). Follistim AQ Cartridge for Injection, Solution. Retrieved from https://www.follistimhcp.com
[2] Novartis Pharmaceuticals. (2022). Follistim Patent Expiration. Retrieved from https://www.follistimhcp.com/expiration/
[3] Follistim Patient Information. Retrieved from https://www.follistimhcp.com/patient-info/